中國投資開發(00204.HK)與播商微谷簽訂戰略合作意向書
格隆匯 3 月 23日丨中國投資開發(00204.HK)發佈公吿,2021年3月18日,公司與杭州播商微谷科技有限公司簽訂戰略合作意向書。
根據披露,播商微谷是一家註冊於杭州的科技公司,主營直播電商,其直播電商業務擁有很好的發展前景,被投價值較高。而公司為香港主板上市公司,有意擴展投資直播電商領域及其他業務,對播商微谷所涉業務有一定投資興趣,公司除有意自身投資外,亦可能引入其他投資者或協助播商微谷融資。此外,雙方同意,待香港疫情緩和之後,公司將安排工作人員對播商微谷專案實地查證及進行盡職調查。意向書項下擬進行的合作事項可望為公司帶來新商機,以開拓新的收入來源,並提高公司及其股東的長遠回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.